Download Citation
Article Source:
Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink
Matthews A,
Langan SM,
Douglas IJ,
Smeeth L,
Bhaskaran K
(2016)
Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink.
PLOS Medicine 13(6): e1002037.
https://doi.org/10.1371/journal.pmed.1002037